TY - JOUR AU - Stathis, A. AU - Moore, M. J. PY - 2010 DA - 2010// TI - Advanced pancreatic carcinoma: current treatment and future challenges JO - Nat. Rev. Clin. Oncol. VL - 7 UR - https://doi.org/10.1038/nrclinonc.2009.236 DO - 10.1038/nrclinonc.2009.236 ID - Stathis2010 ER - TY - JOUR AU - Gudjonsson, B. PY - 2002 DA - 2002// TI - Survival statistics gone awry: pancreatic cancer, a case in point JO - J. Clin. Gastroenterol. VL - 35 UR - https://doi.org/10.1097/00004836-200208000-00011 DO - 10.1097/00004836-200208000-00011 ID - Gudjonsson2002 ER - TY - JOUR AU - Ghaneh, P. AU - Costello, E. AU - Neoptolemos, J. P. PY - 2007 DA - 2007// TI - Biology and management of pancreatic cancer JO - Gut. VL - 56 UR - https://doi.org/10.1136/gut.2006.113068 DO - 10.1136/gut.2006.113068 ID - Ghaneh2007 ER - TY - JOUR AU - Cardenes, H. R. AU - Chiorean, E. G. AU - Dewitt, J. AU - Schmidt, M. AU - Loehrer, P. PY - 2006 DA - 2006// TI - Locally advanced pancreatic cancer: current therapeutic approach JO - Oncologist VL - 11 UR - https://doi.org/10.1634/theoncologist.11-6-612 DO - 10.1634/theoncologist.11-6-612 ID - Cardenes2006 ER - TY - JOUR AU - Vu, T. K. AU - Hung, D. T. AU - Wheaton, V. I. AU - Coughlin, S. R. PY - 1991 DA - 1991// TI - Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation JO - Cell VL - 164 UR - https://doi.org/10.1016/0092-8674(91)90261-V DO - 10.1016/0092-8674(91)90261-V ID - Vu1991 ER - TY - JOUR AU - Salah, Z. PY - 2012 DA - 2012// TI - Regulation of human protease-activated receptor 1 (hPar1) gene expression in breast cancer by estrogen JO - FASEB J. VL - 26 UR - https://doi.org/10.1096/fj.11-194704 DO - 10.1096/fj.11-194704 ID - Salah2012 ER - TY - JOUR AU - Nierodzik, M. L. AU - Karpatkin, S. PY - 2006 DA - 2006// TI - Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype JO - Cancer Cell. VL - 10 UR - https://doi.org/10.1016/j.ccr.2006.10.002 DO - 10.1016/j.ccr.2006.10.002 ID - Nierodzik2006 ER - TY - JOUR AU - Cisowski, J. PY - 2011 DA - 2011// TI - Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer JO - Am. J. Pathol. VL - 179 UR - https://doi.org/10.1016/j.ajpath.2011.03.025 DO - 10.1016/j.ajpath.2011.03.025 ID - Cisowski2011 ER - TY - JOUR AU - Diaz, J. PY - 2012 DA - 2012// TI - Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1 JO - J. Endocrinol. VL - 214 UR - https://doi.org/10.1530/JOE-11-0310 DO - 10.1530/JOE-11-0310 ID - Diaz2012 ER - TY - JOUR AU - Zhu, L. PY - 2012 DA - 2012// TI - Cooperation of protease-activated receptor 1 and integrin alphanubeta5 in thrombin-mediated lung cancer cell invasion JO - Oncol. Rep. VL - 28 UR - https://doi.org/10.3892/or.2012.1851 DO - 10.3892/or.2012.1851 ID - Zhu2012 ER - TY - JOUR AU - Queiroz, K. C. PY - 2014 DA - 2014// TI - Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance JO - Int. J. Cancer. VL - 135 UR - https://doi.org/10.1002/ijc.28726 DO - 10.1002/ijc.28726 ID - Queiroz2014 ER - TY - JOUR AU - Schmidlin, F. AU - Bunnett, N. W. PY - 2001 DA - 2001// TI - Protease-activated receptors: how proteases signal to cells JO - Curr. Opin. Pharmacol. VL - 1 UR - https://doi.org/10.1016/S1471-4892(01)00099-6 DO - 10.1016/S1471-4892(01)00099-6 ID - Schmidlin2001 ER - TY - JOUR AU - Macfarlane, S. R. AU - Seatter, M. J. AU - Kanke, T. AU - Hunter, G. D. AU - Plevin, R. PY - 2001 DA - 2001// TI - Proteinase-activated receptors JO - Pharmacol. Rev. VL - 53 ID - Macfarlane2001 ER - TY - JOUR AU - Rudroff, C. AU - Striegler, S. AU - Schilli, M. AU - Scheele, J. PY - 2001 DA - 2001// TI - Thrombin enhances adhesion in pancreatic cancer in vitro through the activation of the thrombin receptor PAR 1 JO - Eur. J. Surg. Oncol. VL - 27 UR - https://doi.org/10.1053/ejso.2001.1141 DO - 10.1053/ejso.2001.1141 ID - Rudroff2001 ER - TY - JOUR AU - Nutescu, E. A. AU - Shapiro, N. L. AU - Chevalier, A. PY - 2008 DA - 2008// TI - New anticoagulant agents: direct thrombin inhibitors JO - Cardiol. Clin. VL - 26 UR - https://doi.org/10.1016/j.ccl.2007.12.005 DO - 10.1016/j.ccl.2007.12.005 ID - Nutescu2008 ER - TY - JOUR AU - Mungall, D. PY - 2002 DA - 2002// TI - BIBR-1048 Boehringer Ingelheim JO - Curr. Opin. Investig. Drugs. VL - 3 ID - Mungall2002 ER - TY - JOUR AU - Gustafsson, D. PY - 2003 DA - 2003// TI - Oral direct thrombin inhibitors in clinical development JO - J. Int. Med. VL - 254 UR - https://doi.org/10.1046/j.1365-2796.2003.01225.x DO - 10.1046/j.1365-2796.2003.01225.x ID - Gustafsson2003 ER - TY - JOUR AU - Hankey, G. J. AU - Eikelboom, J. W. PY - 2011 DA - 2011// TI - Dabigatran etexilate: a new oral thrombin inhibitor JO - Circulation VL - 123 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.004424 DO - 10.1161/CIRCULATIONAHA.110.004424 ID - Hankey2011 ER - TY - JOUR AU - Nagarakanti, R. PY - 2011 DA - 2011// TI - Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion JO - Circulation VL - 123 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.977546 DO - 10.1161/CIRCULATIONAHA.110.977546 ID - Nagarakanti2011 ER - TY - JOUR AU - Eckman, M. H. AU - Singer, D. E. AU - Rosand, J. AU - Greenberg, S. M. PY - 2011 DA - 2011// TI - Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation JO - Circ. Cardiovasc. Qual. Outcomes. VL - 4 UR - https://doi.org/10.1161/CIRCOUTCOMES.110.958108 DO - 10.1161/CIRCOUTCOMES.110.958108 ID - Eckman2011 ER - TY - JOUR AU - Ezekowitz, M. D. AU - Aikens, T. H. AU - Nagarakanti, R. AU - Shapiro, T. PY - 2011 DA - 2011// TI - Atrial fibrillation: outpatient presentation and management JO - Circulation VL - 124 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.967455 DO - 10.1161/CIRCULATIONAHA.110.967455 ID - Ezekowitz2011 ER - TY - JOUR AU - Scott, K. A. AU - Amirehsani, K. A. PY - 2015 DA - 2015// TI - Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation JO - J. Am. Assoc. Nurse Pract. VL - 27 ID - Scott2015 ER - TY - JOUR AU - Ziske, C. PY - 2008 DA - 2008// TI - Real-time high-resolution compound imaging allows percutaneous initiation and surveillance in an orthotopic murine pancreatic cancer model JO - Pancreas VL - 36 UR - https://doi.org/10.1097/MPA.0b013e3181586cd9 DO - 10.1097/MPA.0b013e3181586cd9 ID - Ziske2008 ER - TY - JOUR AU - Dineen, S. P. PY - 2010 DA - 2010// TI - Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer JO - Cancer Res. VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-3892 DO - 10.1158/0008-5472.CAN-09-3892 ID - Dineen2010 ER - TY - JOUR AU - Alexander, E. T. AU - Minton, A. R. AU - Peters, M. C. AU - Ryn, J. AU - Gilmour, S. K. PY - 2016 DA - 2016// TI - Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.13300 DO - 10.18632/oncotarget.13300 ID - Alexander2016 ER - TY - JOUR AU - Boer, J. D. PY - 2015 DA - 2015// TI - Effect of the oral thrombin inhibitor dabigatran on allergic lung inflammation induced by repeated house dust mite administration in mice JO - Am. J. Physiol. Lung Cell Mol. Physiol. VL - 309 UR - https://doi.org/10.1152/ajplung.00102.2015 DO - 10.1152/ajplung.00102.2015 ID - Boer2015 ER - TY - JOUR AU - Kopec, A. K. PY - 2014 DA - 2014// TI - Thrombin inhibition with dabigatran protects against high-fat-diet-induced fatty liver disease in mice JO - J. Pharmacol. Exp. Ther. VL - 351 UR - https://doi.org/10.1124/jpet.114.218545 DO - 10.1124/jpet.114.218545 ID - Kopec2014 ER - TY - JOUR AU - Marangoni, M. N. PY - 2016 DA - 2016// TI - Differential effects on glial activation by a direct versus an indirect thrombin inhibitor JO - J. Neuroimmunol. VL - 297 UR - https://doi.org/10.1016/j.jneuroim.2016.05.018 DO - 10.1016/j.jneuroim.2016.05.018 ID - Marangoni2016 ER - TY - JOUR AU - Borensztajn, K. PY - 2010 DA - 2010// TI - Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis JO - Am. J. Pathol. VL - 177 UR - https://doi.org/10.2353/ajpath.2010.091107 DO - 10.2353/ajpath.2010.091107 ID - Borensztajn2010 ER - TY - JOUR AU - Duitman, J. PY - 2012 DA - 2012// TI - CCAAT/enhancer-binding protein delta facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner JO - Proc. Natl. Acad. Sci. USA. VL - 109 UR - https://doi.org/10.1073/pnas.1202641109 DO - 10.1073/pnas.1202641109 ID - Duitman2012 ER - TY - JOUR AU - Shi, K. AU - Queiroz, K. C. AU - Stap, J. AU - Richel, D. J. AU - Spek, C. A. PY - 2013 DA - 2013// TI - Protease-activated receptor-2 induces migration of pancreatic cancer cells in an extracellular ATP-dependent manner JO - J. Thromb. Haemost. VL - 11 ID - Shi2013 ER - TY - JOUR AU - Cunningham, D. PY - 2009 DA - 2009// TI - Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer JO - J. Clin. Oncol. VL - 27 UR - https://doi.org/10.1200/JCO.2009.24.2446 DO - 10.1200/JCO.2009.24.2446 ID - Cunningham2009 ER - TY - CHAP AU - Whatcott, C. J. AU - Posner, R. G. AU - Hoff, D. D. AU - Han, H. ED - Grippo, P. J. ED - Munshi, H. G. PY - 2012 DA - 2012// TI - Desmoplasia and chemoresistance in pancreatic cancer. In BT - Pancreatic Cancer and Tumor Microenvironment PB - Transworld Research Network CY - Trivandrum, India ID - Whatcott2012 ER - TY - JOUR AU - Hwang, R. F. PY - 2008 DA - 2008// TI - Cancer-associated stromal fibroblasts promote pancreatic tumor progression JO - Cancer Res. VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-5714 DO - 10.1158/0008-5472.CAN-07-5714 ID - Hwang2008 ER - TY - JOUR AU - Chambers, R. C. AU - Leoni, P. AU - Blanc-Brude, O. P. AU - Wembridge, D. E. AU - Laurent, G. J. PY - 2000 DA - 2000// TI - Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1 JO - J. Biol. Chem. VL - 275 UR - https://doi.org/10.1074/jbc.M003188200 DO - 10.1074/jbc.M003188200 ID - Chambers2000 ER - TY - JOUR AU - Goerge, T. PY - 2006 DA - 2006// TI - Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation JO - Cancer Res. VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-3897 DO - 10.1158/0008-5472.CAN-05-3897 ID - Goerge2006 ER - TY - JOUR AU - Zhang, Y. AU - Wang, Y. AU - Xiang, Y. AU - Lee, W. PY - 2012 DA - 2012// TI - Prohibitins are involved in protease-activated receptor 1-mediated platelet aggregation JO - J. Thromb. Haemost VL - 10 UR - https://doi.org/10.1111/j.1538-7836.2011.04607.x DO - 10.1111/j.1538-7836.2011.04607.x ID - Zhang2012 ER - TY - JOUR AU - Cooper, D. M. AU - Pechkovsky, D. V. AU - Hackett, T. L. AU - Knight, D. A. AU - Granville, D. J. PY - 2011 DA - 2011// TI - Granzyme K activates protease-activated receptor-1 JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0021484 DO - 10.1371/journal.pone.0021484 ID - Cooper2011 ER - TY - JOUR AU - Ramsay, A. J. PY - 2008 DA - 2008// TI - Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression JO - J. Biol. Chem. VL - 283 UR - https://doi.org/10.1074/jbc.M709493200 DO - 10.1074/jbc.M709493200 ID - Ramsay2008 ER - TY - JOUR AU - Knecht, W. PY - 2007 DA - 2007// TI - Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia JO - J. Biol. Chem. VL - 282 UR - https://doi.org/10.1074/jbc.M703840200 DO - 10.1074/jbc.M703840200 ID - Knecht2007 ER - TY - JOUR AU - Jiang, G. PY - 2010 DA - 2010// TI - PRSS3 promotes tumour growth and metastasis of human pancreatic cancer JO - Gut. VL - 59 UR - https://doi.org/10.1136/gut.2009.200105 DO - 10.1136/gut.2009.200105 ID - Jiang2010 ER - TY - JOUR AU - Neesse, A. PY - 2011 DA - 2011// TI - Stromal biology and therapy in pancreatic cancer JO - Gut. VL - 60 UR - https://doi.org/10.1136/gut.2010.226092 DO - 10.1136/gut.2010.226092 ID - Neesse2011 ER - TY - JOUR AU - Borensztajn, K. S. AU - Spek, C. A. PY - 2008 DA - 2008// TI - Protease-activated receptors, apoptosis and tumor growth JO - Pathophysiol. Haemost. Thromb. VL - 36 UR - https://doi.org/10.1159/000175152 DO - 10.1159/000175152 ID - Borensztajn2008 ER - TY - JOUR AU - Tsopanoglou, N. E. AU - Maragoudakis, M. E. PY - 2009 DA - 2009// TI - Thrombin’s central role in angiogenesis and pathophysiological processes JO - Eur. Cytokine Netw. VL - 20 ID - Tsopanoglou2009 ER - TY - JOUR AU - Battinelli, E. M. PY - 2014 DA - 2014// TI - Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-02-485011 DO - 10.1182/blood-2013-02-485011 ID - Battinelli2014 ER - TY - JOUR AU - Haralabopoulos, G. C. AU - Grant, D. S. AU - Kleinman, H. K. AU - Maragoudakis, M. E. PY - 1997 DA - 1997// TI - Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo JO - Am. J. Physiol. VL - 273 UR - https://doi.org/10.1152/ajpcell.1997.273.1.C239 DO - 10.1152/ajpcell.1997.273.1.C239 ID - Haralabopoulos1997 ER - TY - JOUR AU - Wang, B. AU - Pearson, T. AU - Manning, G. AU - Donnelly, R. PY - 2010 DA - 2010// TI - In vitro study of thrombin on tubule formation and regulators of angiogenesis JO - Clin. Appl. Thromb. Hemost. VL - 16 UR - https://doi.org/10.1177/1076029609354332 DO - 10.1177/1076029609354332 ID - Wang2010 ER - TY - JOUR AU - Lange, S. PY - 2014 DA - 2014// TI - Independent anti-angiogenic capacities of coagulation factors X and Xa JO - J. Cell Physiol. VL - 229 UR - https://doi.org/10.1002/jcp.24612 DO - 10.1002/jcp.24612 ID - Lange2014 ER - TY - JOUR AU - Ruffell, B. AU - Affara, N. I. AU - Coussens, L. M. PY - 2012 DA - 2012// TI - Differential macrophage programming in the tumor microenvironment JO - Trends Immunol. VL - 33 UR - https://doi.org/10.1016/j.it.2011.12.001 DO - 10.1016/j.it.2011.12.001 ID - Ruffell2012 ER - TY - JOUR AU - Fischer, C. PY - 2007 DA - 2007// TI - Anti-PLGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels JO - Cell VL - 131 UR - https://doi.org/10.1016/j.cell.2007.08.038 DO - 10.1016/j.cell.2007.08.038 ID - Fischer2007 ER - TY - JOUR AU - Zhang, W. PY - 2010 DA - 2010// TI - Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects JO - Clin. Cancer Res. VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-2904 DO - 10.1158/1078-0432.CCR-09-2904 ID - Zhang2010 ER - TY - JOUR AU - Zeuner, A. PY - 2014 DA - 2014// TI - Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small-cell lung cancer JO - Cell Death Differ. VL - 21 UR - https://doi.org/10.1038/cdd.2014.105 DO - 10.1038/cdd.2014.105 ID - Zeuner2014 ER - TY - JOUR AU - Icli, F. PY - 2007 DA - 2007// TI - Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer JO - J. Surg. Oncol. VL - 95 UR - https://doi.org/10.1002/jso.20728 DO - 10.1002/jso.20728 ID - Icli2007 ER - TY - JOUR AU - Delius, S. PY - 2007 DA - 2007// TI - Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinoma JO - Thromb. Haemost. VL - 98 UR - https://doi.org/10.1160/TH07-01-0004 DO - 10.1160/TH07-01-0004 ID - Delius2007 ER - TY - JOUR AU - Doormaal, F. F. PY - 2011 DA - 2011// TI - Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer JO - J. Clin. Oncol. VL - 29 UR - https://doi.org/10.1200/JCO.2010.31.9293 DO - 10.1200/JCO.2010.31.9293 ID - Doormaal2011 ER - TY - JOUR AU - Qiu, W. AU - Su, G. H. PY - 2013 DA - 2013// TI - Development of orthotopic pancreatic tumor mouse models JO - Methods Mol. Biol. VL - 980 UR - https://doi.org/10.1007/978-1-62703-287-2_11 DO - 10.1007/978-1-62703-287-2_11 ID - Qiu2013 ER - TY - JOUR AU - Partecke, L. I. PY - 2011 DA - 2011// TI - A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines JO - Eur. Surg. Res VL - 47 UR - https://doi.org/10.1159/000329413 DO - 10.1159/000329413 ID - Partecke2011 ER - TY - JOUR AU - Hwang, C. I. AU - Boj, S. F. AU - Clevers, H. AU - Tuveson, D. A. PY - 2016 DA - 2016// TI - Preclinical models of pancreatic ductal adenocarcinoma JO - J. Pathol. VL - 238 UR - https://doi.org/10.1002/path.4651 DO - 10.1002/path.4651 ID - Hwang2016 ER - TY - JOUR AU - Daley, D. PY - 2016 DA - 2016// JO - yS T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation. VL - 166 ID - Daley2016 ER - TY - JOUR AU - Inman, K. S. AU - Francis, A. A. AU - Murray, N. R. PY - 2014 DA - 2014// TI - Complex role for the immune system in initiation and progression of pancreatic cancer JO - World J. Gastroenterol. VL - 20 UR - https://doi.org/10.3748/wjg.v20.i32.11160 DO - 10.3748/wjg.v20.i32.11160 ID - Inman2014 ER - TY - JOUR AU - Monte, L. PY - 2011 DA - 2011// TI - Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer JO - J. Exp. Med. VL - 208 UR - https://doi.org/10.1084/jem.20101876 DO - 10.1084/jem.20101876 ID - Monte2011 ER - TY - JOUR AU - Fukunaga, A. PY - 2004 DA - 2004// TI - CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma JO - Pancreas VL - 28 UR - https://doi.org/10.1097/00006676-200401000-00023 DO - 10.1097/00006676-200401000-00023 ID - Fukunaga2004 ER - TY - JOUR AU - Pylayeva-Gupta, Y. AU - Lee, K. E. AU - Hajdu, C. H. AU - Miller, G. AU - Bar-Sagi, D. PY - 2012 DA - 2012// TI - Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia JO - Cancer Cell. VL - 21 UR - https://doi.org/10.1016/j.ccr.2012.04.024 DO - 10.1016/j.ccr.2012.04.024 ID - Pylayeva-Gupta2012 ER - TY - JOUR AU - Ochi, A. PY - 2012 DA - 2012// TI - MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells JO - J. Exp. Med. VL - 209 UR - https://doi.org/10.1084/jem.20111706 DO - 10.1084/jem.20111706 ID - Ochi2012 ER - TY - JOUR AU - Frese, K. K. AU - Tuveson, D. A. PY - 2007 DA - 2007// TI - Maximizing mouse cancer models JO - Nat. Rev. Cancer VL - 7 UR - https://doi.org/10.1038/nrc2192 DO - 10.1038/nrc2192 ID - Frese2007 ER - TY - JOUR AU - Petersen, L. C. PY - 2005 DA - 2005// TI - Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study JO - Thromb. Res. VL - 116 UR - https://doi.org/10.1016/j.thromres.2004.11.003 DO - 10.1016/j.thromres.2004.11.003 ID - Petersen2005 ER -